media – Page 532 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Takeda moots Shire move but big questions remain

Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an approach for the company.
- Source: takeda
- 640
- April 3, 2018
Company Insights Shire Takeda
Procedures and Requirements of GMP Certification of Pharmaceutical Drugs in the Philippines

According to the latest data, the population of the Philippines has exceeded 100 million, and the demand for various types of medicine shows a steady increase. With the advancement of relations between China and the Philippines and collaborations in economy and trade, the Philippines has become a prime exporting country for Chinese pharmaceutical companies.
- Source: Ddu
- 2,093
- April 3, 2018
Ddu College Philippines
Record Q1 brings in $1.6B for digital health investments, disease diagnosis segment dominates

Investment in digital health rose to its highest level for the first quarter of the year at $1.6 billion compared with $909 million for the same time last year, according to a new report by Rock Health. That figure reflected investment across 77 digital health deals, dominated by the category of disease diagnosis in terms of total investment and monitoring of disease category in terms of deal volume.
- Source: MedCityNews
- 601
- April 3, 2018
Company Insights digital health investment
Tiny ‘hearing’ device is 100,000 times thinner than your eardrum

The super small vibrating sensor can detect signals at the highest reported dynamic range of frequencies, up to ~110dB, at radio frequencies (RF) up to over 120MHz.
- Source: Engadget
- 1,202
- April 3, 2018
medical device Researches wearables
Device able to quickly and accurately detect stroke

A new visor-like device worn by patients can help providers and emergency medical personnel detect a stroke that requires comprehensive care within seconds and with greater than 90 percent accuracy.
- Source: Health Data Management
- 724
- April 3, 2018
FDA medical device New Approvals stroke
EMA to review sotagliflozin as potential treatment for type 1 diabetes

The European Medicines Agency (EMA) has accepted for review Sanofi’s regulatory submission for sotagliflozin. If approved, the oral treatment would be used as an addition to insulin therapy to improve blood sugar control in adults with type 1 diabetes mellitus.
- Source: mediaroom.sanofi
- 571
- April 2, 2018
diabetes New Approvals sotagliflozin
Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab

Shire plc (LSE: SHP, NASDAQ: SHPG) announced today the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for lanadelumab (SHP643) and also reports that Health Canada has completed screening and accepted the New Drug Submission (NDS) under Priority Review for this investigational compound.
- Source: Shire
- 612
- April 2, 2018
angioedema HAE lanadelumab New Approvals
Parkinson’s gene initiates disease outside of the brain

Until very recently, Parkinson's had been thought a disease that starts in the brain, destroying motion centers and resulting in the tremors and loss of movement. New research published this week in the journal Brain, shows the most common Parkinson's gene mutation may change how immune cells react to generic infections like colds, which in turn trigger the inflammatory reaction in the brain that causes Parkinson's. The research offers a new understanding of Parkinson's disease.
- Source: sciencedaily
- 561
- April 2, 2018
immune cells Parkinson’s disease Researches
Calorie restriction trial in humans suggests benefits for age-related disease

One of the first studies to explore the effects of calorie restriction on humans showed that cutting caloric intake by 15% for 2 years slowed aging and metabolism and protected against age-related disease. The study, which will appear March 22 in the journal Cell Metabolism, found that calorie restriction decreased systemic oxidative stress, which has been tied to age-related neurological conditions such as Alzheimer's and Parkinson's diseases, as well as cancer, diabetes, and others.
- Source: sciencedaily
- 574
- April 2, 2018
aging calorie restriction metabolism Researches
Nine digital health mergers and acquisitions from the first quarter of 2018

The first quarter of 2018 was light on mergers and acquisitions compared to previous quarters, but those that did crop up were significant, including major companies like Fitbit, Allscripts, Roche, and Johnson & Johnson.
- Source: MobiHealthNews
- 494
- April 2, 2018
digital health Market Views merger-and-acquisition

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.